Current research on consolidation therapy and follow-up health care in advanced non-small cell lung cancer patients

You have forgotten your username or password, we can .My Menu Saved Items дё­ж–‡(з®ЂдЅ") дё­ж–‡(з№Ѓй«") English Deutsch н•њкµ­м–ґ ж—Ґжњ¬иЄћ Franais Espaol Ш§Щ„Ш№Ш±ШЁЩЉШ© Р СѓСЃСЃРєРёР№ Journal Article CURRENT RESEARCH ON CONSOLIDATION THERAPY AND FOLLOW-UP HEALTH CARE IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS Journal Publisher Chinese Anti-Cancer Association ISSN 1672-7118 (Print) 1993-5145 (Online) Issue DOI 10.Pages 146-149 Subject Collection SpringerLink Date Tuesday, May 20, 2008 Current research on consolidation therapy and follow-up health care in advanced non-small cell lung cancer patients Runbo Zhong1, Baohui Han1 and Bo Jin1 (1) Department of Pulmonary Internal Medicine, Shanghai Chest Hospital, Shanghai, 200030, China RECEIVED: 3 September 2007 ACCEPTED: 24 December 2007 PUBLISHED ONLINE: 11 May 2008 Abstract Following concurrent radio-chemotherapy or first-line chemotherapy for advanced non-small cell lung cancer (NSCLC), continuous maintenance therapy given to patients with stable disease (SD) and follow-up treatment is called consolidation therapy.Patients with a non-operable dry Stage-IIIB (N3) disease, i.Contra-lateral mediastinal and hilar lymph node, or homolateral/contra-lateral scalene and Troisier sign, a 2 or 3-course of standard-dosage Taxotere consolidation therapy can be performed a er concurrent radio-chemotherapy.Pursuance of evidence-based medicine (EBM), low-dose Taxotere maintenance therapy, and biological targeted therapy of patients with appropriate symptoms are suitable for second-line therapy for moist of the Stage-IIIB (malignant pleural effusion) and IV patients.Key Words lung tumor - chemotherapy - radiotherapy - targeted therapy BAOHUI HAN EMAIL: References secured to subscribers.Find Query Builder Close Clear Within all content Within this journal Within this issue Export this article Export this article as RIS Text В© Springer.
Read more Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a hungarian analysis
Get more Genetic variation affects smoking cessation treatment